CD Targeted Cell Therapy Market Size, Share & Trends Analysis Report By Indication Type (Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, and Others), By Target Type, Region And Segment Forecasts, 2023-2031.

Chapter 1.Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2.Executive Summary Chapter 3.Global CD Targeted Cell Therapy Market Snapshot Chapter 4.Global CD Targeted Cell Therapy Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis of Metaverse Industry 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact on Metaverse Industry Chapter 5.Market Segmentation 1: By Indication Type Estimates & Trend Analysis 5.1. By Indication Type & Market Share, 2019-2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Indication Type: 5.2.1. Diffuse large B-cell lymphoma 5.2.2. Chronic lymphocytic leukemia 5.2.3. Multiple myeloma 5.2.4. Acute lymphoblastic leukemia 5.2.5. Others Chapter 6.Market Segmentation 2: By Target Type Estimates & Trend Analysis 6.1. By Target Type & Market Share, 2019-2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Target Type: 6.2.1. CD19 6.2.2. CD20 6.2.3. CD33 Chapter 7.CD Targeted Cell Therapy Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Indication Type, 2023-2031 7.1.2. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031 7.1.3. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031 7.2.2. Europe CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031 7.2.3. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031 7.3.2. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031 7.3.3. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031 7.4.2. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031 7.4.3. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, (US$ Million) 7.5.2. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031 7.5.3. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8.Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Juno Therapeutics 8.2.2. Agios Pharmaceutical 8.2.3. Aurora BioPharma 8.2.4. Atara Biotherapeutics 8.2.5. AryoGen Biopharma 8.2.6. Shenzhen BinDeBio Ltd. 8.2.7. China Immunotech Co., Ltd. 8.2.8. Autolus Limited 8.2.9. Kite Pharma 8.2.10. Bellicum Pharmaceuticals 8.2.11. bluebird bio 8.2.12. Calibr 8.2.13. Carina Biotech 8.2.14. CARsgen Therapeutics 8.2.15. Celgene Corporation 8.2.16. Cellectis 8.2.17. Cell Medica 8.2.18. AbbVie 8.2.19. Allogene Therapeutics 8.2.20. Amgen 8.2.21. Cell Design Labs 8.2.22. Celularity 8.2.23. Celyad 8.2.24. Fate Therapeutics 8.2.25. Fortress Bio 8.2.26. Gilead Sciences 8.2.27. Sorrento Therapeutics, Inc. 8.2.28. Ziopharm 8.2.29. Janssen Biotech 8.2.30. JW Therapeutics 8.2.31. Medisix Therapeutics 8.2.32. Mustang Bio 8.2.33. Nanjing Legend Biotech 8.2.34. Precision Biosciences 8.2.35. Posedia Therapeutics 8.2.36. Other Prominent Players